跳至主要内容
临床试验/2023-503470-21-00
2023-503470-21-00已完成4 期

Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl for sedation in screening colonoscopy: A randomized controlled study

Herlev Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年4月5日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
Total time from start of medication to fulfillment of the discharge criteria

研究概览

简要总结

The overall object of this project is to investigate Remimazolam with Fentanyl compared to Midazolam with Fentanyl for sedation in screening colonoscopy with the primary outcome being total time from start of medication to fulfillment of the discharge criteria. In this way we will examine whether Remimazolam with Fentanyl could create an improvement in procedural sedation by leading to both a shorter procedure as well as shorter recovery time.

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Age over 18
  • Scheduled for elective colonoscopy screening for colon cancer
  • Must be able to provide informed written consent.

排除标准

  • Requiring general anesthesia.
  • Allergy to Midazolam, Remimazolam, opioids or ingredients.

结局指标

主要结局

Total time from start of medication to fulfillment of the discharge criteria

Total time from start of medication to fulfillment of the discharge criteria

次要结局

  • Need for postprocedural recovery room, due to lack of fulfillment of discharge criteria.
  • Patient discomfort/pain rated using NRS-11.
  • Time to reach coecum.
  • Need for additional Fentanyl.
  • Need for additional sedativa.
  • Patient satisfaction.
  • Endoscopist satisfaction
  • Cognitive function at discharge.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Andrea Ambrecht

Scientific

Herlev Hospital

研究点 (1)

Loading locations...

相似试验